NEW YORK, April 2 – Luminex of Austin, Texas, said Monday it had licensed two components of Tm Bioscience’s microarray technology for use in its LabMAP, bead-based genomic analysis system.

Toronto-based Tm has also signed a multi-year partnership with Luminex, granting Tm rights to develop and market diagnostic products based on Luminex's LabMAP technology. LabMap uses microspheres, small lasers, digital processors, and software to perform up to 100 assays per drop of fluid.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.

A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.

Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.

In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.